Showing results (251-260 of 336) with videos related to

Sort By:
Pageof 34
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagusA Harstrick, C Bokemeyer, P Preusser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2009
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancerM Ychou, W Hohenberger, S Thezenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinomaA Harstrick, H J Schmoll, H Wilke, et al.
British Journal of Cancer|August 17, 2000
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancerC Kollmannsberger, D Quietzsch, C Haag, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2010
Phase I trial of SU14813 in patients with advanced solid malignanciesW Fiedler, G Giaccone, P Lasch, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
ESMO Open|January 9, 2021
Supportive care in patients with cancer during the COVID-19 pandemicM Aapro, G H Lyman, C Bokemeyer, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|January 18, 2014
[Ten years of early complex geriatric rehabilitation therapy in the DRG system]G Kolb, K Breuninger, S Gronemeyer, et al.
Anti-Cancer Drugs|June 5, 2002
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancerF Honecker, C Kollmannsberger, D Quietzsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trialD F Bajorin, C R Nichols, H J Schmoll, et al.
Pageof 34